Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force


Averna M., Banach M., Bruckert E., Drexel H., Farnier M., Gaita D., ...Daha Fazla

ATHEROSCLEROSIS, cilt.325, ss.99-109, 2021 (SCI İndekslerine Giren Dergi) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 325
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1016/j.atherosclerosis.2021.03.039
  • Dergi Adı: ATHEROSCLEROSIS
  • Sayfa Sayıları: ss.99-109

Özet

Background and aims: This European Atherosclerosis Society (EAS) Task Force provides practical guidance for combination therapy for elevated low-density lipoprotein cholesterol (LDL-C) and/or triglycerides (TG) in highrisk and very-high-risk patients.